Millennium Gets a Product, and Capabilities

Millennium Pharmaceuticals Inc.'s acquisition of Cor Therapeutics Inc. brings the technology integrator a marketed product (Integrilin), the infrastructure that supports it, and, in Vaughn Kailian, Cor's CEO who will now head Millennium's commercial operations, a highly capable biopharmaceutical executive. The firms says their research programs are complementary--even if they don't appear to be at first glance.